Dr. Thomas Stossel argues for increasing interaction between academic scientists and the companies that manufacture biomedical treatments.
No takes yet. Share an insight, caveat, or question.
Thomas P. Stossel (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: